Literature DB >> 31404023

Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.

Rachel E Simpson1,2, Michele T Yip-Schneider1,2,3,4, Katelyn F Flick1,2, Huangbing Wu1,2, Cameron L Colgate5, C Max Schmidt1,2,3,4,6.   

Abstract

OBJECTIVES: We sought to determine if interleukin (IL)-1β and prostaglandin E2 (PGE2) (inflammatory mediators in pancreatic fluid) together with serum carbohydrate antigen (CA) 19-9 could better predict intraductal papillary mucinous neoplasm (IPMN) dysplasia than individual biomarkers alone.
METHODS: Pancreatic cyst fluid (n = 92) collected via endoscopy or surgery (2003-2016) was analyzed for PGE2 and IL-1β (enzyme-linked immunosorbent assay). Patients had surgical pathology-proven IPMN. Threshold values (PGE2 [>1100 pg/mL], IL-1β [>20 pg/mL], and serum CA 19-9 [>36 U/mL]) were determined.
RESULTS: Levels of IL-1β were higher in high-grade dysplasia (HGD)/invasive-IPMN (n = 42) compared with low/moderate IPMN (n = 37) (median [range], 54.6 [0-2671] vs 5.9 [0-797] pg/mL; P < 0.001; area under curve [AUC], 0.766). Similarly, PGE2 was higher in HGD/invasive IPMN (n = 45) compared with low/moderate IPMN (n = 47) (median [range], 1790 [20-15,180] vs. 140 [10-14,630] pg/mL; P < 0.001; AUC, 0.748). Presence of elevated PGE2 and IL-1β (AUC, 0.789) provided 89% specificity and 82% positive predictive value (PPV) for HGD/invasive IPMN. Elevated levels of all 3 provided 100% specificity and PPV for HGD/invasive IPMN.
CONCLUSIONS: Cyst fluid PGE2, IL-1β, and serum CA 19-9 in combination optimize specificity and PPV for HGD/invasive IPMN and may help build a panel of markers to predict IPMN dysplasia.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31404023      PMCID: PMC6699881          DOI: 10.1097/MPA.0000000000001377

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  36 in total

1.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

2.  Is surgical intervention for cystic neoplasms of the pancreas being underutilized?

Authors:  C Max Schmidt
Journal:  J Gastrointest Surg       Date:  2013-10-30       Impact factor: 3.452

Review 3.  Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.

Authors:  Masao Tanaka; Carlos Fernández-Del Castillo; Terumi Kamisawa; Jin Young Jang; Philippe Levy; Takao Ohtsuka; Roberto Salvia; Yasuhiro Shimizu; Minoru Tada; Christopher L Wolfgang
Journal:  Pancreatology       Date:  2017-07-13       Impact factor: 3.996

4.  Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.

Authors:  Ajay V Maker; Silvia Carrara; Nigel B Jamieson; Mario Pelaez-Luna; Anne Marie Lennon; Marco Dal Molin; Aldo Scarpa; Luca Frulloni; William R Brugge
Journal:  J Am Coll Surg       Date:  2014-11-06       Impact factor: 6.113

5.  Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis.

Authors:  Weilin Wang; Lufei Zhang; Linghui Chen; Jianfeng Wei; Qiang Sun; Qingshong Xie; Xiaohu Zhou; Dongkai Zhou; Pengfei Huang; Qifan Yang; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Biomed Rep       Date:  2014-11-03

6.  Cytology from pancreatic cysts has marginal utility in surgical decision-making.

Authors:  Ajay V Maker; Linda S Lee; Chandrajit P Raut; Thomas E Clancy; Richard S Swanson
Journal:  Ann Surg Oncol       Date:  2008-09-03       Impact factor: 5.344

Review 7.  Pancreatic cysts: preoperative diagnosis and clinical management.

Authors:  Martha Bishop Pitman; Kent Lewandrowski; Jian Shen; Dushyant Sahani; William Brugge; Carlos Fernandez-del Castillo
Journal:  Cancer Cytopathol       Date:  2010-02-25       Impact factor: 5.284

8.  Prevalence of unsuspected pancreatic cysts on MDCT.

Authors:  Thomas A Laffan; Karen M Horton; Alison P Klein; Bruce Berlanstein; Stanley S Siegelman; Satomi Kawamoto; Pamela T Johnson; Elliot K Fishman; Ralph H Hruban
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

9.  Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms.

Authors:  J Y Jang; T Park; S Lee; M J Kang; S Y Lee; K B Lee; Y R Chang; S W Kim
Journal:  Br J Surg       Date:  2014-03-25       Impact factor: 6.939

10.  Systematic Review of Pancreatic Cyst Fluid Biomarkers: The Path Forward.

Authors:  Nikhil Thiruvengadam; Walter G Park
Journal:  Clin Transl Gastroenterol       Date:  2015-06-11       Impact factor: 4.488

View more
  5 in total

Review 1.  Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification.

Authors:  Vincenzo Nasca; Marta Chiaravalli; Geny Piro; Annachiara Esposito; Lisa Salvatore; Giampaolo Tortora; Vincenzo Corbo; Carmine Carbone
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

2.  The association between serum ferritin levels and malignant intraductal papillary mucinous neoplasms.

Authors:  Xiaoling Zhuge; Hao Zhou; Liming Chen; Hui Chen; Xiao Chen; Chuangen Guo
Journal:  BMC Cancer       Date:  2021-11-20       Impact factor: 4.430

Review 3.  Biochemical Intracystic Biomarkers in the Differential Diagnosis of Pancreatic Cystic Lesions.

Authors:  Dominika Wietrzykowska-Grishanovich; Ewa Pawlik; Katarzyna Neubauer
Journal:  Medicina (Kaunas)       Date:  2022-07-26       Impact factor: 2.948

4.  ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis.

Authors:  Tiansuo Zhao; Di Xiao; Fanjie Jin; Xugang Sun; Jie Yu; Hongwei Wang; Jing Liu; Wenrun Cai; Chongbiao Huang; Xiuchao Wang; Song Gao; Zhe Liu; Shengyu Yang; Chuntao Gao; Jihui Hao
Journal:  Br J Cancer       Date:  2022-08-19       Impact factor: 9.075

Review 5.  Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

Authors:  Robert S O'Neill; Alina Stoita
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.